Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010

Forensic Science International

Volumn 212, Issue 1-3, 2011, Pages 242-246

  Schneider, Serge ^a   Meys, François ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Adulterants; Drug purity; Illicit cocaine; Illicit heroin

Indexed keywords

ADULTERANT; CAFFEINE; CHEMICAL COMPOUND; COCAINE; DIAMORPHINE; ILLICIT DRUG; LEVAMISOLE; PARACETAMOL; PHENACETIN; UNCLASSIFIED DRUG;

ARTICLE; AWARENESS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG INFORMATION; DRUG PURITY; DRUG STABILITY; LUXEMBOURG; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TREND STUDY;

EID: 80052317838     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.06.027     Document Type: Article

References (21)

1. Cunningham J., Maxwell J., Campollo O., Cunningham K., Liu L., Lin H. Proximity to the US-Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine and heroin purity. Addiction 2010, 105:1785-1798.
2. Cole C., Jones L., McVeigh J., Kicman A., Syed Q., Bellis M. A guide to adulterants, bulking agents and other contaminants found in illicit drugs 2010, Centre for Public Health, Faculty of Health and Applied Social Sciences, Liverpool.
3. Cole C., Jones L., McVeigh J., Kicman A., Syed Q., Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2010, (Epub ahead of print).
4. Brunt T., Rigter S., Hoek J., Vogels N., van Dijk P., Niesink R. An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 2009, 104:798-805.
5. Baron J. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog. Exp. Tumor Res. 2003, 37:1-24.
6. Fifield M. Renal disease associated with prolonged use of acetophenetidin-containing compounds. N.E.J.M. 1963, 269:722.
7. Grossman E., Messerli F. Calcium antagonists. Prog. Cardiovasc. Dis. 2004, 47:34-57.
8. Rowbotham M.C., Hooker W., Mendelson J., Jones R. Cocaine-calcium channel antagonist interactions. Psychopharmacology 1987, 93:152-154.
9. Zhu N., Legatt D., Turner A. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann. Intern. Med. 2009, 1510:287-289.
10. Symoens J., Veys E., Mielants M., Pinals R. Adverse reactions to levamisole. Cancer Treat. Rep. 1978, 62:1721-1730.
11. Knowles L., Buxton J., Skuridina N., Achebe I., Legatt D., Fan S., Yan Zhu N., Talbot J. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct. J. 2009, 6:30.
12. Fucci N. Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci. Int. 2007, 172:e1.
13. Huizer H. Analytical studies on illicit heroin. V. Efficacy of volatilization during heroin smoking. Pharm. Weekbl. Sci. 1987, 9:203-2011.
14. Terrettaz-Zufferey A., Ratle F., Ribaux O., Esseiva P., Kanevski M. Pattern detection in forensic case data using graph theory: application to heroin cutting agents. Forensic Sci. Int. 2007, 167:242-246.
15. Maurer H., Pfleger K., Weber A. Mass Spectral and GC Data of Drugs, Poisons, Pesticides. Pollutants and Their Metabolites 2007, Wiley-VCH.
16. UNODC World Drug Report 2009 2009, UNODC, Vienna.
17. Chang A., Osterloh J., Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin. Pharmacol. Ther. 2010, 88:408-411.
18. Duflou J., Brouwer I., Darke S. Levamisole as an adulterant in a cocaine overdose fatality. Med. J. Aust. 2010, 192:724.
19. Knox D., Murray G., Millar M., Hamilton D., Connor M., Ferdinand R., Jones G. Subcutaneous anthrax in three intravenous drug users: A new clinical diagnosis. J. Bone Joint Surg. Br. 2011, 93:414-417.
20. Powell A., Crozier J., Hodgson H., Galloway D. A case of septicaemic anthrax in an intravenous drug user. BMC Infect. Dis. 2011, 11(211).
21. Booth M., Hood J., Brooks T., Hart A. Anthrax infection in drug users. Lancet 2010, 375:1345-1346.